{
    "clinical_study": {
        "@rank": "60570", 
        "arm_group": [
            {
                "arm_group_label": "ISR Group", 
                "description": "Patients Group Experienced In-Stent Restenosis (ISR)"
            }, 
            {
                "arm_group_label": "Non-ISR", 
                "description": "Patients Group Without in-stent restenosis (ISR)"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators assessed the hypothesis that whether RH-PAT index (RHI) as a marker of\n      endothelial dysfunction could predict occurrence of ISR after percutaneous coronary\n      intervention (PCI)."
        }, 
        "brief_title": "Impaired Peripheral Endothelial Function and In-stent Restenosis", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective observational study of all consecutive patients with coronary artery\n      disease (CAD) treated with PCI at Kumamoto University Hospital between January 2010 and\n      September 2012. Inclusion criteria consisted of patients who were symptomatic for myocardial\n      ischemia and who were undergoing stent implantation for significant CAD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Inclusion criteria consisted of patients who were symptomatic for myocardial ischemia\n             and who were undergoing stent implantation for significant CAD.\n\n        Exclusion Criteria:\n\n          -  Exclusion criteria were balloon angioplasty only without stent deployment, death\n             during hospitalization, and patients who had comorbidities affected RH-PAT results\n             such as hemodialysis, advanced cancer, after surgery of breast cancer, dementia,\n             collagen disease, and not performing RH-PAT with uncertain reason."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "consecutive patient sampling This is a prospective observational study of all consecutive\n        patients with coronary artery disease (CAD) treated with PCI at Kumamoto University\n        Hospital between January 2010 and September 2012. Inclusion criteria consisted of patients\n        who were symptomatic for myocardial ischemia and who were undergoing stent implantation\n        for significant CAD."
            }
        }, 
        "enrollment": {
            "#text": "513", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131935", 
            "org_study_id": "1120"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kumamoto", 
                    "country": "Japan", 
                    "zip": "860-8556"
                }, 
                "name": "Kumamoto University"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "2", 
        "official_title": "Impaired Peripheral Endothelial Function as Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis", 
        "overall_official": {
            "affiliation": "Kumamoto University", 
            "last_name": "Hisao Ogawa, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Based on the Japanese clinical routine, follow-up (F/U) angiography will be performed at six and nine months after PCI with bare-metal stent (BMS) and drug-eluting stent (DES), respectively. ISR was defined as percent diameter stenosis >50% at F/U angiography assessed by quantitative coronary angiography.", 
            "measure": "Presence or absence of in-stent restenosis", 
            "safety_issue": "No", 
            "time_frame": "within 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131935"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kumamoto University", 
            "investigator_full_name": "Kenichi Tsujita, MD, PhD", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Fingertip reactive hyperemia peripheral arterial tonometry (RH-PAT) is a new device that provides noninvasive, automatic, and quantitative evaluation of endothelial dysfunction with low intra- and inter-observer variability. We assess the hypothesis that whether RH-PAT index (RHI) as a marker of endothelial dysfunction could predict occurrence of ISR after percutaneous coronary intervention (PCI). RHI will be measured using Endo-PAT2000 (Itamar Medical, Caesarea, Israel) before PCI (initial RHI) and at follow-up angiography (F/U RHI) in consecutive patients who had successful PCI in de novo coronary lesions.", 
            "measure": "Endothelial Function", 
            "safety_issue": "No", 
            "time_frame": "within 1 year"
        }, 
        "source": "Kumamoto University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kumamoto University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "May 2014"
    }
}